Objective: To describe two cases of patients who had thrombotic microangiopathy (TMA) associated with sickle cell disease (SCD). Case description: Both patients started with a painful crisis and had ...
A groundbreaking new study introduces an AI-powered smartphone app that noninvasively screens for anemia using a photo of a user's fingernail. The study shows the app provides hemoglobin estimates ...
Anemia occurs when you have fewer red blood cells or low hemoglobin, reducing oxygen levels in your blood. Iron deficiency anemia is common and can be treated with dietary changes and supplements.
Initially, the abdominal symptoms were attributed to side effects of her current medications for inclusion body myositis, overlooking a classic presentation of lead toxicity. Lead toxicity is an ...
Currently no FDA-approved therapies are available for wAIHA, a rare, heterogeneous, life-threatening disease in which pathogenic immunoglobulin (IgG) autoantibodies attach to and destroy red blood ...
Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia Rilzabrutinib is the first and only investigational BTKi ...
Phase 2b LUMINA 2 study data support rilzabrutinib's FDA Breakthrough Therapy designation for the treatment of warm autoimmune hemolytic anemia. The Food and Drug Administration (FDA) has granted ...
Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...
Introduction: Cerebral Infarction due to Severe ADAMTS-13 Deficiency (CISAD) remains an underrecognized cause of cryptogenic stroke. It can be a diagnostic challenge given the absence of ...
CAR T-cell therapies are now being used to treat patients with B-cell driven autoimmune diseases such as lupus. Another such condition is autoimmune hemolytic anemia, in which immune cells destroy red ...
Iron overload is prevalent among adults with sickle cell disease (SCD), according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in Orlando, ...
Patients with myelofibrosis and anemia showed similar spleen size and symptom improvements as the overall JUMP study cohort when treated with ESAs or danazol and Jakafi. The JUMP trial, a phase 3b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results